One possible explanation for this conflicting result is that previous studies employed different RCC cell line, 786-O, with basal expression level of GLDC lower than other RCC cell lines, and our study used ACHN and Caki-2 with basal expression levels of GLDC higher than other RCC cell lines. The gene discussed is GLDC; the disease is renal cell carcinoma.